🔬 MassARRAY® System
AbA Panel Assays & Partner MassARRAY Panel List
📚 แค็ตตาล็อกชุดตรวจวิเคราะห์ทางพันธุกรรมของ Agena Bioscience และชุดตรวจจากพันธมิตร ครอบคลุมงานด้านสุขภาพ มะเร็ง เภสัชพันธุศาสตร์ โรคติดเชื้อ และปศุสัตว์
🧪
0
AbA Panels
🤝
0
Partner Panels
🗂️
0
Categories
🏢
0
Partners / Inventors
PART 1🧫 Assays by Agena (AbA) Panels List
รายการชุดตรวจวิเคราะห์ทางพันธุกรรม
🔍
- 👪 Carrier Screening
- 🦠 Infectious Diseases
- ❤️ Health Check
- 🎗️ Oncology & Relative
- 💊 PGx Panels
- 👶 Newborn Screening
- 🔬 Sample Integrity
| Category | No | Name | Detail | Wells | Genes | Mut Type | Sample Type |
|---|
| No | Name | Detail | Wells | Genes | Mut Type | Sample Type |
|---|---|---|---|---|---|---|
| A010 | Deafness | Deafness genetic screening | 1 | 10 | SNP/del | 🩸 Blood |
| A020 | G6PD Core | Fava bean disease (Favism) | 1 | 1 | SNP | 🩸 Blood |
| A025 | Thalassemia | α-thalassaemia is in the first hole and β-thalassaemia is in the 2nd hole. Alpha-thalassemia detection types include 3.7del, 4.2del, SEA del and THAI del. | 2 | 2 | SNP/del | 🩸 Blood & 🦷 Buccal |
| A026 | SMA & folate metabolism | Spinal Muscular Atrophy (SMA) screening and folate metabolism screening | 1 | 7 | CNV/ SNP | 🧪 Fresh blood / DBS |
| 13162 | CFTR | Cystic Fibrosis carrier screening for the autosomal recessive | 6 | 1 | SNP/del | 🩸 Blood |
| No | Name | Detail | Wells | Gene No / Details | Mut Type | Sample Type |
|---|---|---|---|---|---|---|
| C | Tuberculosis ID Panel | Identify Mycobacterium tuberculosis complex & 30 other Mycobacterium strains | 2 | 2 MTB + 30 NTM | SNP | 🤧 Sputum etc |
| 06190 | Tuberculosis Drug Resistance | 5 first-line and 15 second-line drugs associate variants. | 3 | 5 (1LR) + 15 (2LRS) | SNP | 🤧 Sputum etc |
| 06190 | Tuberculosis Drug Resistance (Ex) | 5 first-line and 15 second-line drugs associate variants. | 2 | 14 TBDR var + 7 NDR var | SNP | 🤧 Sputum etc |
| 13295 | HPV | Detects 12 high risk and 12 low risk HPV strains | 1 | 24 | SNP | ✂️ Biopsies and swab |
| C | STD | 18 pathogens (+ 2 reference assay) | 1 | 18 | SNP | 🧻 Swab, Urine |
| No | Name | Detail | Wells | Genes | Mut Type | Sample Type |
|---|---|---|---|---|---|---|
| A001 | Susceptibility of coronary heart disease | Coronary heart disease susceptibility gene testing | 2 | 48 | SNP | 🩸 Blood |
| A002 | Susceptibility of Cardiovascular disease | Cardiovascular and cerebrovascular susceptibility (essential hypertension, hyperlipidemia, coronary heart disease, atherosclerosis, hemorrhagic stroke, ischemic stroke, atrial fibrillation, Alzheimer's disease, hypertension combined with left ventricular hypertrophy) | 2 | 39 | SNP | 🩸 Blood |
| A005 | Blood cancer | Leukemia: chronic myelogenous leukemia, chronic myelogenous leukemia); lymphoma: B-cell non-Hodgkin lymphoma, Hodgkin lymphoma (nodular sclerosis type), , Hodgkin lymphoma, follicular lymphoma; multiple myeloma susceptibility genes | 1 | 19 | SNP | 🩸 Blood |
| A006 | Susceptibility of breast cancer | breast cancer susceptibility | 2 | 21 | SNP | 🩸 Blood |
| A008 | Diabetes | Type I, type II diabetes, diabetic nephropathy, diabetic eye disease, cardiovascular complications of diabetes, type II diabetic neuropathy | 1 | 14 | SNP | 🩸 Blood |
| A009 | Cardiovascular function | Coronary heart disease and atherosclerosis risk genes, cholesterol and lipoprotein metabolic function, hypertension risk genes, hypercoagulation risk genes, arrhythmia, cardiac arrest risk genes | 2 | 40 | SNP | 🩸 Blood |
| A014 | Weight lost | Lipid metabolism and weight loss | 1 | 13 | SNP/del | 🩸 Blood |
| A015 | Caffeine + alcohol metabolism | Caffeine and drinking metabolism related | 1 | 14 | SNP/del | 🩸 Blood |
| A016 | Susceptibility of cancer | Including at least breast cancer, lung cancer, pancreatic cancer, gastric cancer, liver cancer, skin cancer, colorectal cancer, osteosarcoma, uterine sarcoma, endometrial cancer and other solid tumors | 2 | 43 | SNP | 🩸 Blood |
| A017 | Fitness | Third-party reporting software provides complete reporting solutions | 1 | 25 | SNP | 🩸 Blood & 🦷 Buccal |
| A018 | Susceptibility of gynecopathy | Susceptibility related to gynecological diseases | 1 | 11 | SNP | 🩸 Blood |
| A019 | Folic Acid | Simultaneous testing of folic acid and pregnancy-induced hypertension | 1 | 8 | SNP | 🩸 Blood |
| A021 | Susceptibility of Cardiovascular disease | Cardiovascular disease susceptibility | 1 | 18 | SNV | 🩸 Blood & 🦷 Buccal |
| A022 | Fatness | obesity related genes | 1 | 11 | SNV | 🩸 Blood & 🦷 Buccal |
| A023 | Hypertension | Genes related to hypertension, hyperglycemia and hyperlipidemia | 1 | 14 | SNV | 🩸 Blood & 🦷 Buccal |
| A027 | Skin | Melanin levels in skin, associated with pigmentation/acne/vitiligo | 1 | 19 | SNP | 🩸 Blood & 🦷 Buccal |
| A028 | Asthma susceptibility | Used for general health asthma risk assessment | 1 | 16 | SNP | 🩸 Blood & 🦷 Buccal |
| A029 | Allergy susceptibility | Used for general health allergy risk assessment | 1 | 17 | SNP | 🩸 Blood & 🦷 Buccal |
| No | Name | Detail | Wells | Genes | Mut Type | Sample Type |
|---|---|---|---|---|---|---|
| A024 | Male and female cancer susceptibility | Male tumors (including lung cancer, liver cancer, gastric cancer, acute lymphoblastic leukemia, chronic lymphocytic leukemia, colon cancer, rectal cancer, laryngeal cancer, esophageal cancer, nasopharyngeal cancer, bladder cancer, prostate cancer, etc.) Female tumors (including breast cancer, Ovarian cancer, cervical cancer, esophageal cancer, nasopharyngeal cancer, lung cancer, primary liver cancer, gastric cancer, colon cancer, rectal cancer, laryngeal cancer, bladder cancer, acute lymphoblastic leukemia, chronic lymphocytic leukemia, etc.) | 2 | 49 | SNV | 🩸 Blood & 🦷 Buccal |
| B007 | Cancer Chemo PGx | Cancer drug metabolism, platinum drugs (cisplatin, carboplatin, oxaliplatin, etc.), paclitaxel, docetaxel, fluorouracil, gemcitabine, etc | 3 | 37 | SNP | 🩸 Blood |
| C01 | EBV-LDT | Highly pathogenic EBV mutations causing nasopharyngeal carcinoma and susceptibility to nasopharyngeal carcinoma | 1 | 6 | SNP | 🩸 Blood & 🦷 Buccal |
| D01 | ClearSEEK Lung | An upgraded version of the lung cancer HS panel, used to detect mutations related to lung cancer medication or prognosis, with a lower detection limit of 1% | 4 | 5 | SNV/INDEL | 🧬 FFPE DNA |
| D03 | ClearSEEK CA | Used to detect mutations related to drug use or prognosis in intrahepatic cholangiocarcinoma, with a lower detection limit of 1% | 4 | 12 | SNV | 🧬 FFPE DNA |
| D02 | ClearSEEK Colon | An upgraded version of the lung cancer HS panel, used to detect mutations related to lung cancer medication or prognosis, with a lower detection limit of 1% | 4 | 4 | SNV | 🧬 FFPE DNA |
| A003 | Male Tumor | Cardiovascular and cerebrovascular susceptibility (essential hypertension, hyperlipidemia, coronary heart disease, atherosclerosis, hemorrhagic stroke, ischemic stroke, atrial fibrillation, Alzheimer's disease, hypertension combined with left ventricular hypertrophy) | 1 | 15 | SNP | 🩸 Blood |
| A004 | Female Tumor | Breast cancer, ovarian cancer, endometrial cancer, cervical cancer susceptibility genes | 1 | 21 | SNP | 🩸 Blood |
| A007 | Greater Health 1 | Tumor related | 2 | 53 | SNP | 🩸 Blood |
| No | Name | Detail | Wells | Genes | Mut Type | Sample Type |
|---|---|---|---|---|---|---|
| 13386F | Veridose Core | Tier 1 and Tier 2 recommendations from leading societies across 85 targets | 3 | 16 | SNP/InDel | 🩸 Blood |
| 13358D | Veridose CNV | CYP2D6 copy number variation | 1 | 1 | CNV | 🩸 Blood |
| B001 | Mental PGx | Metabolism of psychotropic drugs, such as: sertraline, escitalopram oxalate, risperidone, atomoxetine, fluoxetine, aripiprazole, etc. | 1 | 19 | SNP/CNV | 🩸 Blood |
| B002 | Nicotine metabolism PGx | Uses Nicotine metabolism to assess the success rate to quit smoking | 1 | 6 | SNP | 🩸 Blood |
| B005 | Pain Killer PGx1 | analgesic drug metabolism | 1 | 9 | SNP | 🩸 Blood |
| B006 | Epilepsy PGx | Epilepsy drug metabolism (diazepam, clobazam, phenytoin, phenobarbital, valproic acid, carbamazepine, etc.) | 1 | 7 | SNP | 🩸 Blood |
| B007 | Cancer Chemotherapy | Cancer drug metabolism, platinum drugs (cisplatin, carboplatin, oxaliplatin, etc.), paclitaxel, docetaxel, fluorouracil, gemcitabine, etc | 3 | 37 | SNP | 🩸 Blood |
| B008 | pain killer PGx2 | Related to the metabolism of analgesic drugs, such as fentanyl, diclofenac, oxycodone, ibuprofen, celecoxib, etc. | 1 | 6 | SNP | 🩸 Blood |
| B009 | Hypertension PGx1 | Beta-adrenoceptor blocking drugs, such as: metoprolol, atenolol, bisoprolol; losartan, angiotensin II receptor antagonists (ARB drugs) | 1 | 7 | SNP/ IN | 🩸 Blood |
| B011 | Cardiovascular | five major categories of common cardiovascular disease drugs and genetic testing (clopidogrel, warfarin, nitroglycerin, statins, hypertension drugs) | 2 | 24 | SNP/InDel | 🩸 Whole blood / dried blood film / oral exfoliated cells / heel blood |
| B013 | Hypertension PGx2 | Aspirin, clopidogrel, ticagrelor, warfarin, dabigatran | 1 | 12 | SNP/INDEL | 🩸 Blood & 🦷 Buccal |
| B014 | Anesthesia PGx | Tamoxifen, warfarin, methadone, tacrolimus, repaglinide, clopidogrel, mephenytoin (anticonvulsants), antidepressants | 1 | 13 | SNP/INDEL | 🩸 Blood |
| B015 | Children PGx30 | Ribavirin, isoniazid, voriconazole, aminoglycoside antibiotics, berberine, lansoprazole, omeprazole, pantoprazole, diclofenac sodium, acetaminophen, ibuprofen, right Dextromethorphan, codeine, oxcarbazepine, diazepam, phenytoin, albuterol, flunisolide, budesonide, folic acid, simvastatin, metformin, aspirin, metoprolol, losartan, nitroglycerin , warfarin, tacrolimus, methylphenidate, cisplatin, methotrexate | 1 | 22 | SNV | 🩸 Blood & 🦷 Buccal |
| B016 | Children PGx50 | Ribavirin, isoniazid, voriconazole, aminoglycoside antibiotics, berberine, lansoprazole, omeprazole, pantoprazole, opioid antipyretics, diclofenac sodium, acetaminophen , ibuprofen, dextromethorphan, codeine, oxcarbazepine, diazepam, phenytoin, corticosteroids, albuterol, flunisolide, budesonide, oral hypoglycemic agents, folic acid, simvastatin, metformin , diuretics, captopril, aspirin, metoprolol, losartan, nitroglycerin, warfarin, tacrolimus, risperidone, methylphenidate, platinum compounds, cytarabine, Pyrimidine analogs, daunorubicin, purine analogs, sunitinib, cisplatin, methotrexate | 2 | 35 | SNV | 🩸 Blood & 🦷 Buccal |
| B017 | Asthma | budesonide, corticosteroids, fluticasone propionate, salmeterol, triamcinolone, salbutamol, Montelukast, glucocorticoid, methacholine, tiotropium, Selective beta-2-adrenoceptor agonist | 2 | 23 | SNP | 🩸 Blood & 🦷 Buccal |
| No | Name | Detail | Wells | Genes | Mut Type | Sample Type |
|---|---|---|---|---|---|---|
| A012 | Deafness | Genetic screening for hereditary deafness (including all deafness-related gene loci currently approved by cFDA) | 1 | 7 | SNP/InDel | 👶 Whole blood / dried blood film / oral exfoliated cells / heel blood |
| C | Small muscular atrophy (SMA) | Spinal Muscular Atrophy (SMA) screening and folate metabolism screening | 1 | 2 | CNV | 🧪 Fresh blood / DBS |
| No | Name | Detail | Wells | Genes | Mut Type | Sample Type |
|---|---|---|---|---|---|---|
| 13116 | Sample ID. | Specimen validity testing (SVT) | 1 | N/A | SNV/del | 🧪 Urine & Buccal |
PART 2🤝 Partner MassARRAY Panel
รายการชุดตรวจพิเศษจากพันธมิตร
| Inventor / Partner | Name | Detail | Wells | Gene / Marker | Mut Type | Sample Type |
|---|---|---|---|---|---|---|
| GENICS | Pork MultiPath™ | PRRSV, PCV2, Influenza, Mycoplasma hyopneumoniae, Actinobacillus pleuropneumoniae, Lawsonia intracellularis, Brachyspira species, Salmonella species | 1 | N/A | SNP | 🦠 Swab, Blood, Tissue |
| GENICS | Shrimp MultiPath™ | WSSV, AHPND, EHP, IHHNV, IMNV, TSV, YHV-1, YHV-7, GAV, DIV1, HPV, MBV, LSNV, MoV, NHP, PvNV, CmNV, MrNV | 1 | N/A | SNP | 🦐 Shrimp Tissue / Pleopod |
| GENICS | ShrimpID™ | Breeding and broodstock management | 1 | N/A | SNP | 🦐 Shrimp Tissue / Pleopod |
| NSTDA | Foodborne Pathogen | Salmonella enterica, Campylobacter spp., Escherichia coli, Listeria monocytogenes, Enterococcus spp., Shigella spp., Staphylococcus aureus, Clostridium perfringens, Vibrio spp., Yersinia spp | 1 | N/A | SNP | 🧪 Food Sample / Swab / Culture |
| Inventor / Partner | Name | Detail | Wells | Gene / Marker | Mut Type | Sample Type |
|---|---|---|---|---|---|---|
| ZS Biotech | Human Gene Mutation | 5 core drugs for lung and colorectal cancer, EGFR C797S | 3 | 5 | SNV/del | 🧬 FFPE |
| Inventor / Partner | Name | Detail | Wells | SNPs No | Sample Type |
|---|---|---|---|---|---|
| HL Science | Obesity & Weight loss | BMI, Obesity, %Fat, Lean body Mass, Visceral | 1 | 17 | 🩸 Blood, Swab |
| HL Science | Gen Health Check | Lipid Metabolism, Blood Glucose, Blood Pressure, Bone Health | 2 | 29 | 🦷 Buccal |
| HL Science | Caffeine & Alcohol & Sleep | Metabolism and Insomnia | 1 | 13 | 🩸 Blood, Swab |
| HL Science | Nutrient | Fe, K, Ca, Mg, Se, Zn, Co-Q10, Lutein, Omega 3, Omega 6, A, B6, B12, C, D, E, K, B9 Storage level | 3 | 49 | 🩸 Blood |
| HL Science | Skin and Hair | Pigment, Aging, Hair loss, Thickness, Wrinkles | 1 | 13 | 🩸 Blood & Buccal |
| L.A.S | Cancer susceptibility | For men, 7 cancers (Lung, Gastric, Liver, Colorectal, Prostate, Thyroid, Pancreatic). For women, 9 cancers (Lung, Gastric, Liver, Colorectal, Breast, Ovarian, Thyroid, Pancreatic, Cervical) | 1 | 36 | 🩸 Blood & Buccal |
| L.A.S | Chronic Disease susceptibility | Alzheimer’s disease; Parkinson disease; Stroke; Myocardial; Hypertension; Diabetes | 1 | 30 | 🩸 Blood & Buccal |
| L.A.S | Additional Cancer and Disease Susceptibility | Meningioma; Bladder carcinoma; Skin cancer; Coronary artery disease; Intracranial aneurysm/brain aneurysm; Rheumatoid arthritis | 1 | 30 | 🩸 Blood & Buccal |
| L.A.S | LAScan Human Microbiome | Lactobacillus 11 species; Bifidobacterium 4 species; Enterococcus 2 species; Lactococcus 1 species; Streptococcus 1 species; Salmonella spp. 1 species; Staphylococcus aureus 1 species; Shigella spp. 1 species; Campylobacter jejuni spp. 1 species; Clostridium difficile 1 species | 2 | 24 | 💩 Stool |
| L.A.S | Pet Gut Microbiome | Lactobacillus 11 species; Bifidobacterium 4 species; Enterococcus 2 species; Lactococcus 1 species; Streptococcus 1 species; Salmonella spp. 1 species; Staphylococcus aureus 1 species; Shigella spp. 1 species; Campylobacter jejuni spp. 1 species; Clostridium difficile 1 species | N/A | N/A | 💩 Stool |
| L.A.S | Pet Disease Susceptibility | Heart, Kidney, Liver, Diabetes, Skin, Joint | N/A | N/A | 🩸 Blood |
| EDGC | Epiclock | Biological Age (methylation/Epigenetics) | 1 | 8 | 🩸 Blood / Buccal |
| DNA Corporation | ADHD I | Risk of Neurological Function | 4 | 54 | 🩸 Blood & Buccal |
| DNA Corporation | ADHD II | Risk of Symptoms | 4 | 54 | 🩸 Blood & Buccal |
| DNA Corporation | Intelli | Intelligence Development | 3 | 43 | 🩸 Blood & Buccal |